GlassScriptPhysician profile
Nicholas D'Angelo
NPI 1689940595
$1,002.85
in general payments reported to CMS, 2019-2025
11 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.41 · 2020: $178 · 2021: $66.84 · 2022: $45.61 · 2023: $120 · 2024: $230 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $340.09 | 2019-2025 | Omnipod, Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $178.52 | 2023-2025 | |
| Inspire Medical Systems, INC. | $139.99 | 2024 | Inspire |
| Gilead Sciences, INC. | $88.38 | 2020-2022 | |
| Novo Nordisk INC | $80.88 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $65.01 | 2020 | |
| Boston Scientific Corporation | $40.12 | 2024 | Wavewriter Alpha Prime 16 |
| Dexcom, INC. | $20.33 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $17.97 | 2024 | Delstrigo, Pifeltro |
| Medtronic, INC. | $15.79 | 2023 | Inpen Smart Insulin Delivery System |
| Xeris Pharmaceuticals, INC. | $15.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.